Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-11-19 19:22:22
Reporting Period:
Accepted Time:
2018-11-19 19:22:22
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1578845 Allergan Plc AGN () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1269428 M Matthew Walsh Clonshaugh Business And Technology Park
Dublin L2 D17 E400
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.0001 Acquisiton 2018-11-16 1,000 $157.00 26,416 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. Includes restricted shares issued pursuant to the Amended and Restated Allergan, Inc. 2011 Incentive Award Plan.